Intervention

T3D-959

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

2 shown

A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease SubjectsNCT06964230 · 2026-10-26

NOT_YET_RECRUITING

Feasibility Study in Subjects With Mild to Moderate Alzheimer's DiseaseNCT02560753 · 2015-07-01

COMPLETED

Common conditions

Alzheimer's Disease2

Leading sponsors

T3D Therapeutics, Inc.2

Trial status mix

COMPLETED1

NOT_YET_RECRUITING1

Phase mix

PHASE22

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.